Minerva Neurosciences
NERV
10 hedge funds and large institutions have $12.6M invested in Minerva Neurosciences in 2014 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
7% less capital invested
Capital invested by funds: $13.6M → $12.6M (-$977K)
17% less funds holding
Funds holding: 12 → 10 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$140K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$863K |
| 2 |
Millennium Management
New York
|
-$91K |
| 3 |
Goldman Sachs
New York
|
-$78.4K |
| 4 |
SIM
Spark Investment Management
New York
|
-$58.2K |
| 5 |
Citigroup
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $9.06M | – | – | – |
|
|
CCA
2
Catalyst Capital Advisors
Huntington,
New York
| $1.78M | – | – | – |
|
|
CAM
3
Cormorant Asset Management
Boston,
Massachusetts
| $1.05M | – | – | – |
|
|
4
Goldman Sachs
New York
| $180K | -$78.4K | -2,055 | -36% |
|
|
5
Federated Hermes
Pittsburgh,
Pennsylvania
| $178K | +$140K | +3,681 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $168K | – | – | – |
|
|
SIM
7
Spark Investment Management
New York
| $151K | -$58.2K | -1,525 | -32% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $11K | +$3.82K | +100 | +78% |
|
|
BIM
9
BlackRock Investment Management
Wilmington,
Delaware
| $5K | – | – | – |
|
10
Morgan Stanley
New York
| $1K | -$114 | -3 | -19% |
|
|
HCMT
11
Highland Capital Management (Texas)
Dallas,
Texas
| – | -$863K | -17,822 | Closed |
|
|
12
Millennium Management
New York
| – | -$91K | -1,890 | Closed |
|
|
13
Citigroup
New York
| – | -$3K | -53 | Closed |
|
NERV Hedge Fund Activity: Q4 2014 in Review
10 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2014, worth a combined $12.6M — down 7.2% from $13.6M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NERV and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Federated Hermes, opening a new position worth an estimated $140K. The largest seller was Highland Capital Management (Texas), exiting entirely with an estimated $863K sold.
- 10 institutional investors held Minerva Neurosciences (NERV) as of Q4 2014, down from 12 in Q3 2014.
- Funds reported $12.6M of Minerva Neurosciences stock for Q4 2014, down 7.2% quarter-over-quarter.
- 1 fund opened new Minerva Neurosciences positions in Q4 2014 and 3 closed out, a net change of -2 holders.
- The largest Minerva Neurosciences buyer in Q4 2014 was Federated Hermes, an estimated $140K added.
- The largest Minerva Neurosciences seller in Q4 2014 was Highland Capital Management (Texas), an estimated $863K sold.
Based on aggregated 13F filings for Q4 2014.